APA (7th ed.) Citation

Sha, Y., Huang, B., Hua, C., Zhu, Y., Tai, W., Sun, J., . . . Jiang, S. (2024). A clinically used anti‐human papilloma virus agent (3‐hydroxyphthalic anhydride‐modified bovine β‐lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus. MedComm, 5(8), . https://doi.org/10.1002/mco2.677

Chicago Style (17th ed.) Citation

Sha, Yi'ou, et al. "A Clinically Used Anti‐human Papilloma Virus Agent (3‐hydroxyphthalic Anhydride‐modified Bovine β‐lactoglobulin) Has a Potential for Topical Application to Prevent Sexual Transmission of Monkeypox Virus." MedComm 5, no. 8 (2024). https://doi.org/10.1002/mco2.677.

MLA (9th ed.) Citation

Sha, Yi'ou, et al. "A Clinically Used Anti‐human Papilloma Virus Agent (3‐hydroxyphthalic Anhydride‐modified Bovine β‐lactoglobulin) Has a Potential for Topical Application to Prevent Sexual Transmission of Monkeypox Virus." MedComm, vol. 5, no. 8, 2024, https://doi.org/10.1002/mco2.677.